tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

IMMX Stock Latest News

Immix Biopharma on Track to Dose NXC-201 Patients in United States
Press ReleasesImmix Biopharma on Track to Dose NXC-201 Patients in United States
8d ago
IMMX
Immix Biopharma says ‘on track’ to dose NXC-201 patients in U.S.
PremiumThe Fly
Immix Biopharma says ‘on track’ to dose NXC-201 patients in U.S.
8d ago
IMMX
Immix Biopharma Announces Late-Breaking NXC-201 Clinical Data Abstract Accepted for Oral Presentation at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
PremiumPress Releases
Immix Biopharma Announces Late-Breaking NXC-201 Clinical Data Abstract Accepted for Oral Presentation at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
11d ago
IMMX
Immix Biopharma Announces Major Comprehensive Cancer Center as Lead Site for NXC-201 AL Amyloidosis Clinical Trial
PremiumPress Releases
Immix Biopharma Announces Major Comprehensive Cancer Center as Lead Site for NXC-201 AL Amyloidosis Clinical Trial
1M ago
IMMX
Immix announces Memorial Sloan Kettering as lead site for NXC-201 trial
PremiumThe Fly
Immix announces Memorial Sloan Kettering as lead site for NXC-201 trial
1M ago
IMMX
Immix Biopharma Announces “Be Proactive in AL” AL Amyloidosis Awareness Initiative
PremiumPress ReleasesImmix Biopharma Announces “Be Proactive in AL” AL Amyloidosis Awareness Initiative
2M ago
IMMX
Immix Biopharma 12 Month Review Progress Update
PremiumPress Releases
Immix Biopharma 12 Month Review Progress Update
2M ago
IMMX
Immix Biopharma Announces Closing of $15 Million Public Offering of Common Stock
PremiumPress Releases
Immix Biopharma Announces Closing of $15 Million Public Offering of Common Stock
3M ago
IMMX
Immix Biopharma Awarded European Union Orphan Drug Designation for NXC-201 in AL Amyloidosis
PremiumPress Releases
Immix Biopharma Awarded European Union Orphan Drug Designation for NXC-201 in AL Amyloidosis
3M ago
IMMX
Immix Biopharma: EC grants orphan drug designation to NXC-201
PremiumThe Fly
Immix Biopharma: EC grants orphan drug designation to NXC-201
3M ago
IMMX
Immix Biopharma Announces New Offering, Sparks Investor Interest
PremiumCompany Announcements
Immix Biopharma Announces New Offering, Sparks Investor Interest
3M ago
8K
IMMX
Immix Biopharma Signs Definitive $15M Titan Partnership Deal
PremiumCompany Announcements
Immix Biopharma Signs Definitive $15M Titan Partnership Deal
3M ago
8K
IMMX
Immix Biopharma 5.5M share priced at $2.71
PremiumThe FlyImmix Biopharma 5.5M share priced at $2.71
3M ago
IMMX
Immix Biopharma Suspends Stock Offering Pending New Prospectus
PremiumCompany Announcements
Immix Biopharma Suspends Stock Offering Pending New Prospectus
3M ago
8K
IMMX
Immix Biopharma Announces Pricing of $15 Million Public Offering of Common Stock
PremiumPress Releases
Immix Biopharma Announces Pricing of $15 Million Public Offering of Common Stock
3M ago
IMMX
Immix Biopharma Announces Proposed Public Offering of Common Stock
PremiumPress Releases
Immix Biopharma Announces Proposed Public Offering of Common Stock
3M ago
IMMX
Immix Biopharma announces common stock offering, no amount given
PremiumThe Fly
Immix Biopharma announces common stock offering, no amount given
3M ago
IMMX
Immix Biopharma Statement On January 2024 FDA Labeling Change Notification For Approved CAR-T Products
PremiumPress Releases
Immix Biopharma Statement On January 2024 FDA Labeling Change Notification For Approved CAR-T Products
3M ago
IMMX
Immix Biopharma ‘applauds’ FDA labeling change notification for CAR-T products
PremiumThe Fly
Immix Biopharma ‘applauds’ FDA labeling change notification for CAR-T products
3M ago
IMMX
Three new option listings on January 24th
PremiumThe FlyThree new option listings on January 24th
3M ago
MYO
IMMX
Immix Biopharma Announces Dr. Vaishali Sanchorawala, AL Amyloidosis Thought Leader, Director of the Amyloidosis Center at Boston University and Boston Medical Center, Joins Scientific Advisory Board
PremiumPress Releases
Immix Biopharma Announces Dr. Vaishali Sanchorawala, AL Amyloidosis Thought Leader, Director of the Amyloidosis Center at Boston University and Boston Medical Center, Joins Scientific Advisory Board
4M ago
IMMX
Immix Biopharma Announces Dr. Marko Radic, Autoimmune CAR-T Pioneer and Associate Professor at the University of Tennessee Health Science Center, Joins Scientific Advisory Board
PremiumPress Releases
Immix Biopharma Announces Dr. Marko Radic, Autoimmune CAR-T Pioneer and Associate Professor at the University of Tennessee Health Science Center, Joins Scientific Advisory Board
4M ago
IMMX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >